Skip to content
Aperlena
Language:

Romania - Antineoplastics - Framework agreement for the supply of antineoplastic medicines

Original România - Antineoplazice - Acord-cadru furnizare ANTINEOPLAZICE

Open Contract notice 30 days left
Watch this tender

Deadline 23 Oct. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 9 Oct, questions by 9 Oct, draft by 16 Oct. Log in

  1. Published
  2. Today
  3. Deadline open for 37 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 67 different companies have won the last 93 comparable contracts from this buyer over 5 years. This is a genuinely open race.

-77.3%
Expected final price vs the published estimate

Based on 93 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The contracting authority is procuring antineoplastic (cancer treatment) medicines through a framework agreement divided into 23 lots, in accordance with the specifications in annex no. 1. The medicines listed include aflibercept, amivantamab, bevacizumab (originator), cisplatin, cyclophosphamide, doxorubicin (including liposomal formulations), durvalumab, irinotecan, methotrexate and Onko BCG for intravesical use. Each product carries maximum annual quantities and maximum quantities per framework agreement, expressed in vials or sets. Clarification requests will be answered clearly and completely by the contracting authority 10 days before the offer submission deadline, and clarifications may be requested up to 18 days before that deadline.

Description

Achizitie ANTINEOPLAZICE 23 loturi conform caiet sarcini-anexa nr.1. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 18 AFLIBERCEPTUM fl 25mg/ml- 8 ml (200MG) CANT MAX AC: 100/FL CANT MAX CS: 33/FL; AFLIBERCEPTUM fl 25mg/ml-4ml (100MG) CANT MAX AC: 100/FL CANT MAX AC: 33/FL; AMIVANTAMABUM conc pt sol perf 350 mg CANT MAX AC: 100/FL CANT MAX CS: 33/FL; BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 100 mg CANT MAX AC: 500/FL CANT MAX CS: 167/FL; BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 400 mg CANT MAX AC: 600/FL CANT MAX CS: 200/FL; CISPLATINUM conc pt sol perf 1 mg/ml-fl 25 ml CANT MAX AC: 900/FL CANT MAX CS: 300/FL; CYCLOPHOSPHAMIDUM CONC. PT. SOL. PERF 500 mg/ml CANT MAX AC: 300/FL CANT MAX CS: 100/FL; CYCLOPHOSPHAMIDUM pulb.pt. sol perf iv 200mg CANT MAX AC: 800/FL CANT MAX CS: 267/FL; DOXORUBICINUM conc pt sol perf 2 mg/ml - fl 50 ml CANT MAX AC: 200/FL CANT MAX CS: 67/FL; DOXORUBICINUM conc pt sol perf 2 mg/ml - fl 25 ml CANT MAX AC: 400/FL CANT MAX CS: 133/FL; DOXORUBICINUM pulb.conc.disp lipozom pt perf 50mg x 2 seturi (cu 3 fl/set) CANT MAX AC: 30/SET CANT MAX CS: 10/SET; DOXORUBICINUM( lipozomală polietilenglicată)2 mg/ml conc. pt. sol. perf.-fl 25ml CANT MAX AC: 30/FL CANT MAX CS: 10/FL; DURVALUMABUM CONC. PT. SOL. PERF 50 mg/ml, fl a 2,4 ml conc. (care conţine 120 mg durvalumab) CANT MAX AC: 100/FL CANT MAX CS: 33/FL; IRINOTECANUM 4,3 mg/ml)CONC. PT. DISPERSIE PERF.-10ml CANT MAX AC: 210/FL CANT MAX CS: 70/FL; METHOTREXAT sol inj 5000 mg/50 ml CANT MAX AC: 100/FL CANT MAX CS: 33/FL; ONKO BCG 100 pulbere si solvent pentru suspensie intravezicala cu 1 flac. din sticla continand 100 mg pulb. si 1 fiola din sticla, cu capacitatea de 2,0 ml ,care contine 1 ml solv. pt. susp. intravezicala CANT MAX AC: 2000/FI CANT MAX CS: 667/FI; RAMUCIRUMABUM CONC. PT. SOL. PERF 10mg/ml x 2 fl/cutie CANT MAX AC: 400/FL CANT MAX CS: 133/FL; TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 0.25mg CANT MAX AC: 100/FL CANT MAX CS: 33/FL; TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 1mg CANT MAX AC: 150/FL CANT MAX CS: 50/FL; TRASTUZUMABUM DERUXTECANUM pulb.pt.conc.pt. sol.perf. 100 mg CANT MAX AC: 200/FL CANT MAX CS: 67/FL; TREMELIMUMABUM CONC. PT. SOL. PERF 20mg/ml-15 ml CANT MAX AC: 10/FI CANT MAX CS: 3/FI; VINBLASTINUM SOL INJ.1mg/ml-10ml CANT MAX AC: 60/FL CANT MAX CS: 20/FL; VINCRISTINUM PULB. PT. SOL. INJ./PERF. I V 1mg-10ml CANT MAX AC: 60/FL CANT MAX CS: 20/FL

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 14 hours ago

View the official notice

More from this buyer

Full buyer profile

4 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
B. BRAUN AVITUM; KAPAMED INTERNATIONAL 8 €2.3M Sep 2026
DR.MAX; ALLIANCE HEALTHCARE ROMANIA 4 €7.5M Sep 2026
A.M.S. 2000 TRADING IMPEX S.R.L.; CLINI-LAB; Medist; Top Diagnostics S.R.L. 4 €829,260 Jul 2026
DG DIAGNOSTICS S.R.L.; ROCHE ROMANIA; Sante International S.A.; BIOMAXIMA CLINICAL S.R.L.; SYNTTERGY CONSULT; MEDICLIM S.R.L.; CLINI-LAB; Medist; HDL Union; A.M.S. 2000 TRADING IMPEX; ATLANCO EXIM S.R.L.; Novaintermed S.R.L. 2 €3.9M Aug 2026
FARMEXIM S.A.; ALLIANCE HEALTHCARE ROMANIA; DR.MAX; DONA. LOGISTICA; FILDAS TRADING; FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L.; FRESENIUS KABI ROMANIA; Romastru Trading; BIOEEL; ROCHE ROMANIA; COMPANIA NATIONALA UNIFARM 2 €3.6M Sep 2026

Based on 93 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 88 comparable contracts this buyer awarded in this sector over the last 4 years.

€121,851
Lower quartile
€321,710
Median award
€1.5M
Upper quartile

This tender is estimated 444.4% above that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€9,941,267
9,626 open across Europe right now 82% below sector average
Buyer track record on Aperlena
114 notices tracked · 98 awarded
€70,307,072 in awarded contracts

Never miss a tender like this

276 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

30 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close